ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.369,94
-0,64%
S&P 500
5.375,32
0,27%
Dow Jones
38.747,42
-0,31%
Euro vs US Dollar
1,07403
0,00%
Bitcoin
67.050,63
-0,41%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Hubei Minkang Pharmaceutical Ltd (GM) (HBMK)

  7. Hubei Minkang Pharmaceutical Ltd (GM) (HBMK) News

HBMK

Hubei Minkang Pharmaceut... (GM) (HBMK)

Hubei Minkang Pharmaceutical Ltd (GM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:HBMK
DatumZeitQuelleÜberschriftSymbolFirma
31/03/201514h55Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
14/08/201422h29Edgar (US Regulatory)Quarterly Report (10-q)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
20/05/201422h18Edgar (US Regulatory)Quarterly Report (10-q)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
16/05/201419h39Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
15/04/201422h51Edgar (US Regulatory)Annual Report (10-k)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
31/03/201423h18Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
18/09/201323h01OTC MarketsVenue ChangeUSOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
14/08/201318h21Edgar (US Regulatory)Quarterly Report (10-q)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
01/08/201320h19Edgar (US Regulatory)Current Report Filing (8-k)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
24/06/201318h11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
10/06/201322h45Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
15/05/201323h21Edgar (US Regulatory)Quarterly Report (10-q)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
01/04/201318h51Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
01/04/201318h51Edgar (US Regulatory)Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
01/04/201318h51Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
27/03/201320h22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
27/03/201320h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
27/03/201320h04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
27/03/201319h55Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
31/01/201319h21Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
31/01/201319h21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
19/11/201219h15Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
19/11/201219h15Edgar (US Regulatory)Quarterly Report (10-q)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
14/11/201220h25Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
14/11/201220h25Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
11/09/201222h53Edgar (US Regulatory)Amended Quarterly Report (10-Q/A)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
20/08/201222h05Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
14/08/201219h17Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
18/05/201218h27Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
15/05/201223h01Edgar (US Regulatory)Current report filing (8-K)USOTC:HBMKHubei Minkang Pharmaceutical Ltd (GM)
 Showing the most relevant articles for your search:USOTC:HBMK

Kürzlich von Ihnen besucht

USOTC
VIHDD
Vision Energy (QB)
BIT
F13348
Vontobel Financial Produ...
BIT
P1Y0J4
NLBNPIT1Y0J4 20351221 11...
BIT
GS0119
Goldman Sachs
BIT
F17367
Vontobel Financial Produ...
BIT
AL2060
Banca Aletti and C
BIT
P1VIO1
NLBNPIT1VIO1 20240621 2400
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten